During the past decade, Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung" #1 collaborator was "BioLineRx, Ltd." with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Halozyme Therapeutics" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Solid Tumors" (2 trials), "Adenocarcinoma" (1 trials) and "Adenocarcinoma, Papillary" (1 trials). Many other conditions were trialed in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung" are "Drug" (18 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Bevacizumab" (3 trials), "Cisplatin" (3 trials), "Cobimetinib" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung, 5 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".